<?xml version="1.0" encoding="iso-8859-1"?>
<?xml-stylesheet type="text/xsl" href="../rssStyle.xslt" version="1.0"?>
<rss version="2.0">
  <channel>
    <title>Biocompare Industry News</title>
    <description>Biocompare.com RSS feed</description>
    <link>http://www.biocompare.com/</link>
    <copyright>&amp;copy; 2010 Biocompare.com</copyright>
    <pubDate>Sun, 01 Aug 2010 02:35:59 GMT</pubDate>
    <docs>http://backend.userland.com/rss</docs>
    <generator>RSS.NET: http://www.rssdotnet.com/</generator>
    <item>
      <title>2010 Addressing Psoriasis(TM) Contest Winners Attend A Style Consultation With Tim Gunn In New York City</title>
      <description>Amgen and Pfizer today announced the five winners of the 2010 Addressing  Psoriasis(TM) contest, which recognizes people with moderate to severe plaque psoriasis who want to feel more confident in their everyday style.</description>
      <link>http://news.biocompare.com/newsstory.asp?id=335744</link>
      <author>Biocompare.com</author>
      <pubDate>Thu, 29 Jul 2010 09:29:00 GMT</pubDate>
    </item>
    <item>
      <title>Article One Announces Completion Of Funding From Alleghany Corporation</title>
      <description>Article One Partners, the world's largest patent research community, today announced the completion of a $5 million round of institutional funding with Alleghany Capital Corporation, a subsidiary of Alleghany Corporation , and other investors. The funding will be used to further consolidate the firm's leading position in the global online patent validation sector by enhancing existing products and services, developing new ones and accelerating sales. Article One added a record number of clients in the first half of fiscal year 2010, bringing the total number of clients to 40, including 12 of the Fortune 100.</description>
      <link>http://news.biocompare.com/newsstory.asp?id=335379</link>
      <author>Biocompare.com</author>
      <pubDate>Wed, 28 Jul 2010 03:59:00 GMT</pubDate>
    </item>
    <item>
      <title>Carl Zeiss Offers Online Promotions - Discounts On Stereomicroscopy And Converting To 3D Imaging</title>
      <description>Carl Zeiss, a leading provider of microscopy solutions for a variety of research, clinical and industrial applications, recently announced two exciting online promotions. These special web promotions are now being extended through to August 31, 2010. These promotions include a price reduction on Zeiss's top-rated stereomicroscopy instrument and a 5 percent discount for conversion of certain existing models of Zeiss research microscopes into a 3D imaging workstation.</description>
      <link>http://news.biocompare.com/newsstory.asp?id=335371</link>
      <author>Biocompare.com</author>
      <pubDate>Tue, 27 Jul 2010 20:57:00 GMT</pubDate>
    </item>
    <item>
      <title>Clontech Laboratories, Inc. &amp; TET Systems Announce The Broadening Of Their License Agreement And The Upcoming Launch Of The New Tet-OnŽ 3GT Inducible Expression System</title>
      <description>Clontech Laboratories, Inc., a wholly-owned subsidiary of Takara Bio Inc., and TET Systems (TET), a privately-held German biotech company based in Heidelberg, today announced that they have signed an amendment to their existing license agreement. Under the expanded license agreement, Clontech obtains rights to develop, manufacture and commercialize novel Tet Systems products as the Tet-OnŽ 3GT Inducible Expression System (www.clontech.com/teton3g ).</description>
      <link>http://news.biocompare.com/newsstory.asp?id=335312</link>
      <author>Biocompare.com</author>
      <pubDate>Tue, 27 Jul 2010 10:07:00 GMT</pubDate>
    </item>
    <item>
      <title>Ampio Pharmaceuticals, Inc. Announces Acquisition Of DMI BioSciences, Inc.</title>
      <description>Ampio Pharmaceuticals, Inc.  today announced it has finalized negotiations with the directors of DMI BioSciences, Inc. (DMI) to acquire DMI BioSciences, Inc.  This acquisition will give Ampio access to all rights, royalties and patents associated with DMI's major assets, drugs for male sexual dysfunction including premature ejaculation (PE) and combination drugs to treat premature ejaculation and erectile dysfunction (ED). These assets are protected by multiple issued U.S. and international patents and additional patent fillings.  Ampio will also receive valuable Phase III clinical trial data accumulated for the treatment of premature ejaculation.</description>
      <link>http://news.biocompare.com/newsstory.asp?id=335310</link>
      <author>Biocompare.com</author>
      <pubDate>Tue, 27 Jul 2010 04:50:00 GMT</pubDate>
    </item>
    <item>
      <title>Colorcon Acquires Business Of Pharmaceutical Coatings Pvt. Ltd. (India)</title>
      <description>Colorcon, Inc. today announced the acquisition of the business of Pharmaceutical Coatings Pvt. Ltd. (India) which includes the company's full product portfolio, plus a new facility in Goa that is currently under construction.</description>
      <link>http://news.biocompare.com/newsstory.asp?id=335242</link>
      <author>Biocompare.com</author>
      <pubDate>Tue, 27 Jul 2010 04:48:00 GMT</pubDate>
    </item>
    <item>
      <title>Merck KGaA, Darmstadt, Germany Completes Millipore Acquisition And Launches New EMD Millipore Division (Merck Millipore Division Outside U.S. And Canada)</title>
      <description>Merck KGaA*, a global pharmaceutical and chemical company, today announced the successful completion of its acquisition of Millipore Corporation (formerly NYSE: MIL), a leading Life Science company based in Billerica, Massachusetts, USA, for an aggregate purchase price including debt and cash of approximately $7.0 billion.</description>
      <link>http://news.biocompare.com/newsstory.asp?id=334880</link>
      <author>Biocompare.com</author>
      <pubDate>Thu, 22 Jul 2010 18:11:00 GMT</pubDate>
    </item>
    <item>
      <title>Two Industry Leaders - Proliant Health And Biologicals And Lampire Biological Laboratories - Form Strategic Partnership To Provide Bovine Serum Albumin</title>
      <description>Lampire Biological Laboratories (LBL) announced today that it signed an agreement with Proliant Health and Biologicals (Proliant), manufacturer of the worlds most trusted, high quality Bovine Serum Albumin (BSA), to do contract filling &amp; provide BSA to customers requiring less than Proliant's standard 10 kilogram packaging. Lampire will also offer made-to-order aqueous blends in buffers and package sizes to customer specifications.</description>
      <link>http://news.biocompare.com/newsstory.asp?id=334874</link>
      <author>Biocompare.com</author>
      <pubDate>Thu, 22 Jul 2010 17:49:00 GMT</pubDate>
    </item>
    <item>
      <title>DNAGenotek Joins Business Coalition Taking Frontline Action Against Hiv/Aids, Tb And Malaria</title>
      <description>DNA Genotek, a leading provider of products for biological sample collection, stabilization and preparation, has joined the Global Business Coalition on HIV/AIDS, Tuberculosis and Malaria.</description>
      <link>http://news.biocompare.com/newsstory.asp?id=334833</link>
      <author>Biocompare.com</author>
      <pubDate>Thu, 22 Jul 2010 06:36:00 GMT</pubDate>
    </item>
    <item>
      <title>CCS Cell Culture Service Celebrates Its 10th Anniversary</title>
      <description>CCS Cell Culture Service GmbH, which was founded in early 2000 by the Hamburg scientist Dr. Oliver Klotzsche and his three partners, was originally dedicated to provide all kinds of cell culture related services. Within the last decade the company has advanced to one of the leading suppliers of cells and cell based reagents for pharmaceutical industries. Meanwhile CCS has 20 employees. Last year CCS launched its subsidiary at the east coast of the USA and has thereby opened a new chapter in the book of its success.</description>
      <link>http://news.biocompare.com/newsstory.asp?id=334832</link>
      <author>Biocompare.com</author>
      <pubDate>Thu, 22 Jul 2010 06:32:00 GMT</pubDate>
    </item>
  </channel>
</rss>